WINTER GARDEN, Fla. — AdventHealth Winter Garden has received accreditation as a Center of Excellence in Hernia Surgery, a designation that recognizes the hospital’s high standard of quality patient care and safety. The certification was issued by the Surgical Review Corporation (SRC), an internationally recognized, nonprofit patient-safety organization dedicated to recognizing and refining surgical care.
“The achievement of this accreditation reflects AdventHealth Winter Garden's commitment to providing the highest standard of care to its hernia patients from the first consultation through postoperative care,” said Dr. Miles Bennett, chief medical officer at AdventHealth Winter Garden. “We are proud to receive this certification, which validates our commitment to our patients' health and safety.”
The hospital is the first in Central Florida to receive this accreditation.
"In achieving this accreditation, our surgeons demonstrate their commitment to ensuring hernia patients receive the highest quality care,” said Dr. Jorge L. Florin, general surgeon and director of Hernia Center at AdventHealth Winter Garden. “Our goal is to provide our West Orange County community with world-class, patient-focused care.”
“Hernias affect our patients’ quality of life,” said Dr. Alexander Schroeder, general surgeon and co-director of Hernia Center at AdventHealth Winter Garden. “The hernia center puts the focus on the patient as a whole.”
Health care facilities seeking an SRC accreditation undergo an extensive assessment and inspection process to ensure the applicant meets SRC’s proven standards and requirements. These requirements include surgical volumes, facility equipment, clinical pathways and standardized operating procedures, an emphasis on patient education and continuous quality assessment. Inspectors educate staff in the accredited departments on best practices to help an organization improve its care and services.
“We’re proud to recognize AdventHealth Winter Garden for its commitment to advancing and providing quality care for all patients,” said Gary M. Pratt, CEO of SRC. “This accreditation signals that this facility is among the best in this specialty and is dedicated to delivering the highest level of care possible.”
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
News
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
News
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
News
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
News
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
News
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
News
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
News
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
News
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
News
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
News
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
News
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...